On the recordApril 25, 2022
In light of the decision by CMS, do you question the FDA's decisionmaking regarding Aduhelm's accelerated approval?
Source
congress.govIn light of the decision by CMS, do you question the FDA's decisionmaking regarding Aduhelm's accelerated approval?
Senator Collins questions the FDA's decision-making after CMS's coverage determination.
Share
More from Susan Collins
I am asking U.S. Sens. Susan Collins and Angus King and U.S. Rep. Jared Golden, who represents Maine’s 2nd Congressional District, my home district, to listen to Maine families, oppose the proposed rule, and protect the standards and…
I believe that we should create a commission of independent financial experts to give us advice on what should be done.
It’s a critical program and the foundation of retirement income for most Mainers, and I’ve voted repeatedly to preserve it.